eNauka - pregled

Pregled prema Projekat Genentech

Prikaz rezultata 1 do 11 od 11
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2012A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexateMease, P; Strand, Vibeke; Shalamberidze, L; Dimic, Aleksandar N; Raskina, T; Xu, Li-An; Liu, Y; Smith, JNaučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2020Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLCHerbst, Roy S; ...; Andric, Zoran G; ...; (broj, koautora 22)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2015Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agentsKarmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20)Naučni članak
21M21 - Rad u vrhunskom međ. časopisu
2022Clinical Trial Readiness for Spinal Muscular Atrophy: Experience of an International Educational-Training InitiativeTizzano, Eduardo F; Christie-Brown, Vanessa; Baranello, Giovanni; Germanenko, Olga; Gray, Allyson; Krstic, Marija; Lilien, Charlotte; Patel, Hinal; Servais, Laurent; Scoto, MariacristinaNaučni članak
22M22 - Rad u istaknutom međ. časopisu
2023Comparative study of virulence factor genes, beta-hemolysis and biofilm production in invasive and colonizing enterococciJovanovic, Milica M; Velebit, Branko M  ; Tosic, Tanja O; Maki, Gina; Pavic, Sladjana; Jovanovic, Snezana; Stosovic, Rajica S; Zervos, Marcus JNaučni članak
23M23 - Rad u međ. časopisu
2016Efficacy analysis of opicinumab in relapsing multiple sclerosis: the Phase 2b SYNERGY trial.Cadaviv, Diego; Edwards, KR; Hupperts, Raymond; Drulovic, Jelena S  ; Montalban, Xavier; Hartung, H-P; Brochet, B; Calabresi, PA; Rudick, R; Ibrahim, Adama;
Zhang, Yiwei; Xu, Lei;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2014Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic ArthritisDavi, Sergio; ...; Susic, Gordana Z; ...; (broj, koautora 43)Naučni članak
23M23 - Rad u međ. časopisu
2020Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE).Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2016Reappraising Immunoglobulin Repertoire Restrictions in Chronic Lymphocytic Leukemia: Focus on Major Stereotyped Subsets and Closely Related SatellitesAgathangelidis, Andreas; Hadzidimitriou, Anastasia; Minga, Eva; Sutton, Lesley-Ann; Polychronidou, Eleftheria; Shanafelt, Tait D.; Davis, Zadie; Yan, Xiao-Jie; Plevova, Karla; Boudjoghra, Myriam;
Navarro, Alba; Rossi, Davide; Pedersen, Lone Bredo; Bikos, Vasilis; Baliakas, Panagiotis; Scarfo, Lydia; Mattsson, Mattias; Xochelli, Aliki; di Celle, Paola Francia; Giannopoulos, Krzysztof; Vanura, Katrina; Evers, Ludo; Veronese, Silvio; Facco, Monica; Moschonas, Panagiotis; Bystry, Vojtech; Karan-Đurašević, Teodora  ; Roumelioti, Maria; Pavlović, Sonja  ; Mansouri, Larry; Chu, Charles; Stalika, Evangelia; Giudicelli, Veronique; Panagiotidis, Panagiotis; Sudarikov, Andrey; Anagnostopoulos, Achilles; Trentin, Livio; Catherwood, Mark; Montillo, Marco; Stavroyianni, Niki; Gaidano, Gianluca; Campo, Elias; Niemann, Carsten Utoft; Langerak, Anton W.; Pospisilova, Sarka; Lefranc, Marie-Paule; Jaeger, Ulrich; Kater, Arnon; Pott, Christiane; Chiorazzi, Nicholas; Oscier, David; Jelinek, Diane F.; Stilgenbauer, Stephan; Hallek, Michael; Tzovaras, Dimitrios; Darzentas, Nikos; Belessi, Chrysoula; Davi, Frederic; Rosenquist, Richard; Ghia, Paolo; Stamatopoulos, Kostas;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 studyCho, Byoung Chul; ...; Secen, Nevena M; ...; (broj, koautora 19)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2021Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLCJassem, Jacek; ...; Andric, Zoran G; ...; (broj, koautora 19)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti